Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice

Conny Th M Van Oostrom, Miranda Boeve, Jolanda D. Van Den Berg, Annemieke De Vries, Martijn E T Dollé, Rudolf B. Beems, Coen F. Van Kreijl, Jan Vijg, Harry Van Steeg

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

XPA-deficient mice have a complete deficiency in nucleotide excision repair, and as such they display a cancer predisposition after exposure to several carcinogens. Besides being sensitive to genotoxic agents applied to the skin, they are also susceptible to human carcinogens given orally, like benzo[a]pyrene (B[a]P). To study the role of the tumor suppressor gene p53 in DNA repair, gene mutation, and tumor induction, we crossed XPA-deficient mice with p53 knockout mice and lacZ (pUR288) gene marker mice. When treated orally (by gavage) with B[a]P, the XPA(-/-)/p53(+/-) double transgenic mice developed tumors much earlier and with higher frequency compared to their single transgenic counterparts. The major tumor type found in all genotypes was generalized lymphoma mainly residing in the spleen; several sarcomas were observed in p53(+/-) and XPA(-/-)/p53(+/-) mice. Next, we determined lacZ mutation frequencies in several (non)target tissues. It appeared that in the spleen (the major tumor target tissue) of XPA(-/-) and XPA(-/-)/p53(+/-) mice the lacZ mutation frequency was significantly elevated (80100 x 10-5), and was two times higher as found in spleens of B[a]P-treated WT and p53(+/-) mice (P = 0.003). In nontumor target tissues like liver and lung, we found a moderate increase in the lacZ gene mutation frequency (30-40 x 10-5), which was independent of the genotype. The results obtained with the DNA-repair deficient XPA mice indicate that a significantly increased lacZ mutation frequency in a particular organ/tissue is an early marker for tumor development at later stages at the same site. However, the synergistic effect of a XPA(-/-)- and a p53(+/-)-deficiency in tumor development is not reflected by an absolute increase in the lacZ mutation frequency in the major tumor target tissue of XPA(-/-)/p53(+/-) or p53(+/-) mice compared to that of XPA(-/-) and WT mice, respectively.

Original languageEnglish (US)
Pages (from-to)124-130
Number of pages7
JournalEnvironmental and Molecular Mutagenesis
Volume34
Issue number2-3
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

DNA Repair-Deficiency Disorders
Benzo(a)pyrene
pyrene
tumor
repair
Tumors
mutation
Repair
DNA
Mutation
Mutation Rate
Tissue
Genes
Neoplasms
gene
Carcinogens
carcinogen
Lac Operon
Spleen
DNA Repair

Keywords

  • Benzo[a]pyrene
  • lacZ
  • Mutagenesis
  • p53
  • Transgenic mice
  • Tumor induction
  • Xeroderma pigmentosum
  • XPA

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Genetics
  • Genetics(clinical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. / Van Oostrom, Conny Th M; Boeve, Miranda; Van Den Berg, Jolanda D.; De Vries, Annemieke; Dollé, Martijn E T; Beems, Rudolf B.; Van Kreijl, Coen F.; Vijg, Jan; Van Steeg, Harry.

In: Environmental and Molecular Mutagenesis, Vol. 34, No. 2-3, 1999, p. 124-130.

Research output: Contribution to journalArticle

Van Oostrom, Conny Th M ; Boeve, Miranda ; Van Den Berg, Jolanda D. ; De Vries, Annemieke ; Dollé, Martijn E T ; Beems, Rudolf B. ; Van Kreijl, Coen F. ; Vijg, Jan ; Van Steeg, Harry. / Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. In: Environmental and Molecular Mutagenesis. 1999 ; Vol. 34, No. 2-3. pp. 124-130.
@article{2d41a2a8f3d44327aeab8f89a7fa6ed6,
title = "Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice",
abstract = "XPA-deficient mice have a complete deficiency in nucleotide excision repair, and as such they display a cancer predisposition after exposure to several carcinogens. Besides being sensitive to genotoxic agents applied to the skin, they are also susceptible to human carcinogens given orally, like benzo[a]pyrene (B[a]P). To study the role of the tumor suppressor gene p53 in DNA repair, gene mutation, and tumor induction, we crossed XPA-deficient mice with p53 knockout mice and lacZ (pUR288) gene marker mice. When treated orally (by gavage) with B[a]P, the XPA(-/-)/p53(+/-) double transgenic mice developed tumors much earlier and with higher frequency compared to their single transgenic counterparts. The major tumor type found in all genotypes was generalized lymphoma mainly residing in the spleen; several sarcomas were observed in p53(+/-) and XPA(-/-)/p53(+/-) mice. Next, we determined lacZ mutation frequencies in several (non)target tissues. It appeared that in the spleen (the major tumor target tissue) of XPA(-/-) and XPA(-/-)/p53(+/-) mice the lacZ mutation frequency was significantly elevated (80100 x 10-5), and was two times higher as found in spleens of B[a]P-treated WT and p53(+/-) mice (P = 0.003). In nontumor target tissues like liver and lung, we found a moderate increase in the lacZ gene mutation frequency (30-40 x 10-5), which was independent of the genotype. The results obtained with the DNA-repair deficient XPA mice indicate that a significantly increased lacZ mutation frequency in a particular organ/tissue is an early marker for tumor development at later stages at the same site. However, the synergistic effect of a XPA(-/-)- and a p53(+/-)-deficiency in tumor development is not reflected by an absolute increase in the lacZ mutation frequency in the major tumor target tissue of XPA(-/-)/p53(+/-) or p53(+/-) mice compared to that of XPA(-/-) and WT mice, respectively.",
keywords = "Benzo[a]pyrene, lacZ, Mutagenesis, p53, Transgenic mice, Tumor induction, Xeroderma pigmentosum, XPA",
author = "{Van Oostrom}, {Conny Th M} and Miranda Boeve and {Van Den Berg}, {Jolanda D.} and {De Vries}, Annemieke and Doll{\'e}, {Martijn E T} and Beems, {Rudolf B.} and {Van Kreijl}, {Coen F.} and Jan Vijg and {Van Steeg}, Harry",
year = "1999",
doi = "10.1002/(SICI)1098-2280(1999)34:2/3<124::AID-EM11>3.0.CO;2-F",
language = "English (US)",
volume = "34",
pages = "124--130",
journal = "Environmental and Molecular Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "2-3",

}

TY - JOUR

T1 - Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice

AU - Van Oostrom, Conny Th M

AU - Boeve, Miranda

AU - Van Den Berg, Jolanda D.

AU - De Vries, Annemieke

AU - Dollé, Martijn E T

AU - Beems, Rudolf B.

AU - Van Kreijl, Coen F.

AU - Vijg, Jan

AU - Van Steeg, Harry

PY - 1999

Y1 - 1999

N2 - XPA-deficient mice have a complete deficiency in nucleotide excision repair, and as such they display a cancer predisposition after exposure to several carcinogens. Besides being sensitive to genotoxic agents applied to the skin, they are also susceptible to human carcinogens given orally, like benzo[a]pyrene (B[a]P). To study the role of the tumor suppressor gene p53 in DNA repair, gene mutation, and tumor induction, we crossed XPA-deficient mice with p53 knockout mice and lacZ (pUR288) gene marker mice. When treated orally (by gavage) with B[a]P, the XPA(-/-)/p53(+/-) double transgenic mice developed tumors much earlier and with higher frequency compared to their single transgenic counterparts. The major tumor type found in all genotypes was generalized lymphoma mainly residing in the spleen; several sarcomas were observed in p53(+/-) and XPA(-/-)/p53(+/-) mice. Next, we determined lacZ mutation frequencies in several (non)target tissues. It appeared that in the spleen (the major tumor target tissue) of XPA(-/-) and XPA(-/-)/p53(+/-) mice the lacZ mutation frequency was significantly elevated (80100 x 10-5), and was two times higher as found in spleens of B[a]P-treated WT and p53(+/-) mice (P = 0.003). In nontumor target tissues like liver and lung, we found a moderate increase in the lacZ gene mutation frequency (30-40 x 10-5), which was independent of the genotype. The results obtained with the DNA-repair deficient XPA mice indicate that a significantly increased lacZ mutation frequency in a particular organ/tissue is an early marker for tumor development at later stages at the same site. However, the synergistic effect of a XPA(-/-)- and a p53(+/-)-deficiency in tumor development is not reflected by an absolute increase in the lacZ mutation frequency in the major tumor target tissue of XPA(-/-)/p53(+/-) or p53(+/-) mice compared to that of XPA(-/-) and WT mice, respectively.

AB - XPA-deficient mice have a complete deficiency in nucleotide excision repair, and as such they display a cancer predisposition after exposure to several carcinogens. Besides being sensitive to genotoxic agents applied to the skin, they are also susceptible to human carcinogens given orally, like benzo[a]pyrene (B[a]P). To study the role of the tumor suppressor gene p53 in DNA repair, gene mutation, and tumor induction, we crossed XPA-deficient mice with p53 knockout mice and lacZ (pUR288) gene marker mice. When treated orally (by gavage) with B[a]P, the XPA(-/-)/p53(+/-) double transgenic mice developed tumors much earlier and with higher frequency compared to their single transgenic counterparts. The major tumor type found in all genotypes was generalized lymphoma mainly residing in the spleen; several sarcomas were observed in p53(+/-) and XPA(-/-)/p53(+/-) mice. Next, we determined lacZ mutation frequencies in several (non)target tissues. It appeared that in the spleen (the major tumor target tissue) of XPA(-/-) and XPA(-/-)/p53(+/-) mice the lacZ mutation frequency was significantly elevated (80100 x 10-5), and was two times higher as found in spleens of B[a]P-treated WT and p53(+/-) mice (P = 0.003). In nontumor target tissues like liver and lung, we found a moderate increase in the lacZ gene mutation frequency (30-40 x 10-5), which was independent of the genotype. The results obtained with the DNA-repair deficient XPA mice indicate that a significantly increased lacZ mutation frequency in a particular organ/tissue is an early marker for tumor development at later stages at the same site. However, the synergistic effect of a XPA(-/-)- and a p53(+/-)-deficiency in tumor development is not reflected by an absolute increase in the lacZ mutation frequency in the major tumor target tissue of XPA(-/-)/p53(+/-) or p53(+/-) mice compared to that of XPA(-/-) and WT mice, respectively.

KW - Benzo[a]pyrene

KW - lacZ

KW - Mutagenesis

KW - p53

KW - Transgenic mice

KW - Tumor induction

KW - Xeroderma pigmentosum

KW - XPA

UR - http://www.scopus.com/inward/record.url?scp=0032696287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032696287&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2280(1999)34:2/3<124::AID-EM11>3.0.CO;2-F

DO - 10.1002/(SICI)1098-2280(1999)34:2/3<124::AID-EM11>3.0.CO;2-F

M3 - Article

VL - 34

SP - 124

EP - 130

JO - Environmental and Molecular Mutagenesis

JF - Environmental and Molecular Mutagenesis

SN - 0893-6692

IS - 2-3

ER -